​

IQVIA (IQV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IQV Stock Forecast

IQVIA (IQV) stock forecast, based on 40 Wall Street analysts, predicts a 12-month average price target of $256.67, with a high of $270.00 and a low of $235.00. This represents a 72.91% increase from the last price of $148.44.

$100 $140 $180 $220 $260 $300 High: $270 Avg: $256.67 Low: $235 Last Closed Price: $148.44

IQV Stock Rating

IQVIA stock's rating consensus is Buy, based on 40 Wall Street analysts. The breakdown includes 1 Strong Buy (2.50%), 32 Buy (80.00%), 7 Hold (17.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 40 7 32 1 Strong Sell Sell Hold Buy Strong Buy

IQV Price Target Upside V Benchmarks

TypeNameUpside
StockIQVIA72.91%
SectorHealthcare Stocks 33.91%
IndustryDiagnostics & Research Stocks45.48%
IdeaSaaS Stocks List32.04%

Price Target Trends

1M3M12M
# Anlaysts--13
Avg Price Target--$259.88
Last Closing Price$148.44$148.44$148.44
Upside/Downside--75.07%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 255155--25
Mar, 257145--26
Feb, 257155--27
Jan, 257154--26
Dec, 247154--26
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 04, 2024Jaliendra SinghTruist Financial$265.00$210.1926.08%78.52%
Oct 31, 2024Elizabeth AndersonEvercore ISI$235.00$205.8214.18%58.31%
Oct 29, 2024Sean DodgeRBC Capital$270.00$217.5424.12%81.89%
Oct 16, 2024Justin BowersDeutsche Bank$270.00$232.9815.89%81.89%
Oct 14, 2024Jamie ClarkRedburn Partners$276.00$229.2620.39%85.93%
Sep 20, 2024Eric ColdwellRobert W. Baird$256.00$244.624.65%72.46%
Aug 05, 2024Jonathan BlockStifel Nicolaus$175.38$236.24-25.76%18.15%
Jul 23, 2024Jailendra SinghTruist Financial$300.00$240.2724.86%102.10%
Jul 23, 2024Elizabeth AndersonEvercore ISI$270.00$239.5012.73%81.89%
Jul 23, 2024Luke SergottBarclays$275.00$245.2312.14%85.26%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 03, 2025BTIGBuyNeutraldowngrade
Dec 19, 2024StephensOverweightinitialise
Nov 01, 2024Cowen & Co.BuyBuyhold
Nov 01, 2024BTIGBuyBuyhold
Oct 29, 2024RBC CapitalOutperformOutperformhold
Oct 16, 2024Deutsche BankBuyBuyhold
Sep 04, 2024RBC CapitalOutperformUnderperforminitialise
Sep 03, 2024RBC CapitalOutperforminitialise
Jul 24, 2024JefferiesHolddowngrade
Jul 23, 2024Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

$0 $4 $8 $12 $16 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.46$5.05$5.82$7.39$7.57----
Avg Forecast$6.31$8.91$10.15$10.19$11.12$11.92$13.28$14.73$16.44
High Forecast$6.43$9.08$10.36$10.21$11.17$12.16$15.49$16.25$16.73
Low Forecast$6.23$8.79$9.99$10.17$11.10$11.61$11.72$12.58$15.94
Surprise %-76.86%-43.32%-42.66%-27.48%-31.92%----

Revenue Forecast

$11B $13B $15B $16B $18B $20B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.36B$13.87B$14.41B$14.98B$15.40B----
Avg Forecast$11.20B$13.83B$14.38B$14.91B$15.38B$16.04B$17.01B$18.04B$19.49B
High Forecast$11.35B$14.02B$14.61B$14.92B$15.39B$16.21B$17.01B$18.06B$19.76B
Low Forecast$11.08B$13.68B$14.21B$14.90B$15.35B$15.68B$17.01B$18.02B$19.03B
Surprise %1.44%0.32%0.20%0.49%0.18%----

Net Income Forecast

$0 $700M $1B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$279.00M$966.00M$1.09B$1.36B$1.37B----
Avg Forecast$268.05M$896.18M$1.17B$1.36B$2.07B$2.21B$2.54B$2.69B$3.06B
High Forecast$329.82M$1.08B$1.41B$1.63B$2.08B$2.27B$2.89B$3.03B$3.12B
Low Forecast$206.28M$716.94M$938.68M$1.09B$2.07B$2.16B$2.18B$2.34B$2.97B
Surprise %4.09%7.79%-7.02%--33.80%----

IQV Forecast FAQ

Is IQVIA stock a buy?

IQVIA stock has a consensus rating of Buy, based on 40 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 32 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that IQVIA is a favorable investment for most analysts.

What is IQVIA's price target?

IQVIA's price target, set by 40 Wall Street analysts, averages $256.67 over the next 12 months. The price target range spans from $235 at the low end to $270 at the high end, suggesting a potential 72.91% change from the previous closing price of $148.44.

How does IQVIA stock forecast compare to its benchmarks?

IQVIA's stock forecast shows a 72.91% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the diagnostics & research stocks industry (45.48%), leading the saas stocks list (32.04%) investment idea.

What is the breakdown of analyst ratings for IQVIA over the past three months?

  • April 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 26.92% Strong Buy, 53.85% Buy, 19.23% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 25.93% Strong Buy, 55.56% Buy, 18.52% Hold, 0% Sell, 0% Strong Sell.

What is IQVIA’s EPS forecast?

IQVIA's average annual EPS forecast for its fiscal year ending in December 2025 is $11.92, marking a 57.46% increase from the reported $7.57 in 2024. Estimates for the following years are $13.28 in 2026, $14.73 in 2027, and $16.44 in 2028.

What is IQVIA’s revenue forecast?

IQVIA's average annual revenue forecast for its fiscal year ending in December 2025 is $16.04B, reflecting a 4.09% increase from the reported $15.4B in 2024. The forecast for 2026 is $17.01B, followed by $18.04B for 2027, and $19.49B for 2028.

What is IQVIA’s net income forecast?

IQVIA's net income forecast for the fiscal year ending in December 2025 stands at $2.21B, representing an 61.26% increase from the reported $1.37B in 2024. Projections indicate $2.54B in 2026, $2.69B in 2027, and $3.06B in 2028.